10x Genomics financials at a glance

+ Portfolio

The revenue of 10x Genomics is reported as 0.61873 billion Dollars in the fiscal year 2023. The earnings were -0.23 Dollars per share in 2023, which was 11.54 higher than 2022. And about -0.0638 billion Dollars are reported as free cash flow in the financials of 10x Genomics 2023. No dividends were paid to the shareholders of the 10x Genomics stock NasdaqGS:TXG in the financial year 2023.

$618.73M

Revenue

$-0.23

Earnings Per Share

66.15%

Gross Margin %

$-,324.00M

Free Cash Flow

Revenue

618.73

Earnings Per Share

-0.23

Gross Margin %

66.15

Free Cash Flow

-,324.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019
Rev.	Revenue	N/A	$618.73M	$516.41M	$490.49M	$298.85M	$245.89M
GM %	Gross Margin %	69.87%	66.15%	76.69%	84.89%	83.61%	87.05%
OM	Operating Margin	-31.99%	-31.51%	-32.52%	-10.79%	-24.50%	0.05%
EPS	Earnings Per Share	$-1.92	$-0.23	$-0.26	$-0.53	$-0.91	$-0.80
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	119.17M	115.36M	112.84M	108.75M	96.55M
OCF	Operating Cash Flow	N/A	$-15.20M	$-33.61M	$-21.37M	$-,217.90M	$34.63M
FCF	Free Cash Flow	N/A	$-,324.00M	$-,165.27M	$-,122.65M	$-,254.56M	$-8.12M
FCFS	Free Cash Flow Per Share	$-0.97	$-0.55	$-1.45	$-1.11	$-2.53	$-0.21

10x Genomics financials at a glance

Financials

Discover